Target intelligence / Profile preview

Fibrin degradation product D-dimer (D-dimer)

Target
D-dimer
Molecular classification
Other
01

Overview

D-dimer is a specific fibrin degradation product formed when cross-linked fibrin clots are broken down by plasmin during the process of fibrinolysis. It is a small protein fragment present in the blood only when acute or chronic activation of coagulation and fibrinolysis has occurred, such as in venous thromboembolism, disseminated intravascular coagulation, or major inflammatory states[2][3][6]. D-dimer is composed of two D fragments of fibrin, joined by a cross-link, and is detected in plasma when the coagulation cascade results in the formation of cross-linked fibrin, and subsequent fibrinolysis occurs[1][3][4]. Measurement of D-dimer in blood is widely used as a **diagnostic biomarker** to exclude or monitor thrombotic events, but it is not itself a molecular drug target, receptor, or enzyme. Because D-dimer is not a receptor, enzyme, transporter, or mediator of biological effects, but rather an **excreted marker of clot breakdown**, it is not subject to pharmacologic modulation or direct drug binding.

Other names
D dimerFDP D-dimerFibrin D-dimerFibrin degradation product D-dimer
02

Biological functions

Blood coagulation monitoringFibrinolysis markerInflammation marker
03

Disease associations

Cardiovascular diseaseThrombosisDisseminated intravascular coagulationInfectionInflammationCancerOther
04

Safety considerations

Elevated D-dimer is non-specific; increase may occur in infection, cancer, inflammation, pregnancy, trauma, and other conditions. False positives and overuse of D-dimer testing can lead to unnecessary investigations or patient anxiety[2][3].
05

Biomarkers

D-dimer is used as a biomarker for thrombotic disorders (e.g., venous thromboembolism, deep vein thrombosis, pulmonary embolism), coagulation activation, disseminated intravascular coagulation, and inflammatory states[2][3][6].

Beyond the preview

Go deeper on Fibrin degradation product D-dimer (D-dimer).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fibrin degradation product D-dimer (D-dimer).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call